Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 9-MTH group results

Feb 14 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             29.73               60.21            45.50    
                 (-50.6 pct)         (+31.9 pct)      (-41.8 pct) 
  Operating        336 mln              19.40             3.00    
                 (-98.3 pct)         (-2.6 pct)       (-85.4 pct) 
  Recurring        586 mln              19.48             3.20    
                 (-97.0 pct)         (-3.3 pct)       (-84.5 pct) 
  Net              154 mln              14.60             2.00    
                 (-98.9 pct)         (+1.6 pct)       (-87.5 pct) 
  EPS             1.28 yen           121.21 yen        16.61 yen  
  Ann Div                             42.00 yen        17.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             42.00 yen        17.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news